ARTICLE | Clinical News
Penederm Inc regulatory update
January 8, 1996 8:00 AM UTC
DERM amended its NDAs for retinoic acid cream and gel products to treat acne. In April, the FDA issued a not approvable letter for the NDAs, citing manufacturing and clinical issues. DERM said it beli...